title: Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.
abstract: A recent report described serum anti-GQ1b ganglioside antibodies in Miller Fisher syndrome (MFS), a clinical variant of Guillain-Barré syndrome (GBS). Four consecutive cases of MFS all had high titre anti-GQ1b antibodies which were absent from all control sera including those of patients with GBS.
authors.affiliation: University Department of Neurology, Southern General Hospital, Glasgow, UK.
authors.forename: H J
authors.initials: HJ
authors.lastname: Willison
authors.forename: J
authors.initials: J
authors.lastname: Veitch
authors.forename: G
authors.initials: G
authors.lastname: Paterson
authors.forename: P G
authors.initials: PG
authors.lastname: Kennedy
mesh_terms: D001323:Autoantibodies / Q000276:immunology*; D002855:Chromatography, Thin Layer; D003429:Cross Reactions / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D011129:Polyradiculoneuropathy / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D005732:Gangliosides; D007074:Immunoglobulin G; D007075:Immunoglobulin M; C039129:GQ1b ganglioside